| Jiangyan Du, PHARMD | |
|
901 Nevin Ave, Richmond, CA 94801-3143 | |
| (510) 307-4851 | |
| Not Available |
| Full Name | Jiangyan Du |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 901 Nevin Ave, Richmond, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023783289 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 84741 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jiangyan Du, PHARMD 3801 Howe St # G80, Oakland, CA 94611-5312 Ph: () - | Jiangyan Du, PHARMD 901 Nevin Ave, Richmond, CA 94801-3143 Ph: (510) 307-4851 |
News Archive
Milestone Scientific Inc. which develops, manufactures, and markets computer-controlled injection systems for medical and dental markets, today announced that its common stock has commenced trading on the OTCQB(TM) electronic quotation and trading system under the ticker symbol MLSS.PK. Stockholders are not required to take any action as a result of the addition of the Company's securities to the OTCQB(TM).
In an article examining recent developments at the Global Fund to Fight AIDS, Tuberculosis and Malaria, the Wall Street Journal interviews Gabriel Jaramillo, the Colombian-born Brazilian citizen and former CEO of Sovereign Bank who will become the fund's new general manager this week.
A team of researchers at Wayne State University's Parent Health Lab in the School of Medicine have developed a novel indirect screener that identifies women at risk for drug use by evaluating correlates of illicit drug use rather than drug use itself. In phase I testing, this new screener proved to be more sensitive than any alternative approach at detecting recent drug use.
University at Buffalo researchers have identified a new mechanism that plays a central role in adult brain stem cell development and prompts brain stem cells to differentiate into neurons.
Orexigen® Therapeutics, Inc. and Takeda Pharmaceutical Company Limited, today announced that they have entered into an exclusive partnership to develop and commercialize Contrave® (naltrexone SR/bupropion SR), Orexigen's investigational drug for the treatment of obesity, in the United States, Canada and Mexico.
› Verified 4 days ago
Temitope Omotayo, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 901 Nevin Ave, Skyview Pharmacy, Richmond, CA 94801 Phone: 510-520-3985 | |
Iok I Tang, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1150 Macdonald Ave, Richmond, CA 94801 Phone: 510-236-5748 | |
Nicholas Do, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 901 Nevin Ave, Richmond, CA 94801 Phone: 510-307-1515 | |
Mr. Paul Pastina, PHARM D CGP Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1400 Pinnacle Ct, 115, Richmond, CA 94801 Phone: 510-235-4246 | |
Mrs. Susan N Kalaei, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4500 Macdonald Ave, T1507, Richmond, CA 94805 Phone: 510-253-1001 Fax: 510-253-1011 | |
Pauline Lai-toledo, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 901 Nevin Ave, Richmond, CA 94801 Phone: 510-307-3161 |